Antiretroviral drugs for AIDS
- 1 September 1996
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 348 (9030), 800-803
- https://doi.org/10.1016/s0140-6736(95)12333-4
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Second Coreceptor for HIV in Early Stages of InfectionScience, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- HIV suppression by interleukin-16Nature, 1995
- Phase I Study of Atevirdine, a Nonnucleoside Reverse Transcriptase Inhibitor, in Combination with Zidovudine for Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 1995
- Improved brain delivery and in vitro activity of zidovudine through the use of a redox chemical delivery systemAIDS, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987